Acadia Healthcare (NASDAQ:ACHC) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Wednesday, December 27th.
A number of other brokerages have also recently issued reports on ACHC. Jefferies Group set a $60.00 target price on shares of Acadia Healthcare and gave the stock a “buy” rating in a research report on Wednesday, October 11th. Citigroup cut their target price on shares of Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th. Cantor Fitzgerald lowered their price target on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating for the company in a report on Tuesday, October 24th. Deutsche Bank downgraded shares of Acadia Healthcare from a “buy” rating to a “hold” rating and lowered their price target for the stock from $60.00 to $37.00 in a report on Wednesday, October 25th. Finally, Zacks Investment Research downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Thursday, October 12th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and eight have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $44.17.
Acadia Healthcare (ACHC) opened at $34.38 on Wednesday. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. The stock has a market cap of $3,020.00, a PE ratio of 17.54, a price-to-earnings-growth ratio of 1.12 and a beta of 0.90. Acadia Healthcare has a 52-week low of $26.92 and a 52-week high of $54.34.
In related news, Director Reeve B. Waud sold 100,000 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.80, for a total value of $3,180,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 11.10% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in ACHC. Schwab Charles Investment Management Inc. grew its holdings in Acadia Healthcare by 13.8% in the second quarter. Schwab Charles Investment Management Inc. now owns 330,515 shares of the company’s stock valued at $16,321,000 after purchasing an additional 40,119 shares during the period. SG Americas Securities LLC purchased a new stake in Acadia Healthcare in the second quarter valued at approximately $280,000. Bank of New York Mellon Corp grew its holdings in Acadia Healthcare by 79.7% in the second quarter. Bank of New York Mellon Corp now owns 1,250,363 shares of the company’s stock valued at $61,744,000 after purchasing an additional 554,368 shares during the period. Legal & General Group Plc grew its holdings in Acadia Healthcare by 130.8% in the second quarter. Legal & General Group Plc now owns 59,435 shares of the company’s stock valued at $2,934,000 after purchasing an additional 33,679 shares during the period. Finally, Comerica Bank purchased a new stake in Acadia Healthcare in the second quarter valued at approximately $2,488,000.
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2018/01/12/acadia-healthcare-achc-upgraded-to-hold-by-bidaskclub.html.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.